Pavelka, K., Szekanecz, Z., Damjanov, N., Anić, B., Tomšič, M., Mazurov, V., . . . Fleischmann, R. (2020). Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: A subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients. Drugs Context.
Dyfyniad Arddull ChicagoPavelka, Karel, et al. "Upadacitinib Versus Placebo or Adalimumab With Background Methotrexate in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: A Subgroup Analysis of a Phase III Randomized Controlled Trial in Central and Eastern European Patients." Drugs Context 2020.
Dyfyniad MLAPavelka, Karel, et al. "Upadacitinib Versus Placebo or Adalimumab With Background Methotrexate in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: A Subgroup Analysis of a Phase III Randomized Controlled Trial in Central and Eastern European Patients." Drugs Context 2020.